| Identification | Back Directory | [Name]
2,3-BIS(4-HYDROXYPHENYL)-PROPIONITRILE | [CAS]
1428-67-7 | [Synonyms]
DPN
SC-4473
Diarylpropionitrile
2,3-bis(p-hydroxyphenyl)propionitrile
2,3-BIS(4-HYDROXYPHENYL)-PROPIONITRILE
propionitrile,2,3-bis(p-hydroxyphenyl)
2,3-Bis(4-hydroxyphenyl)propanenitrile
2,3-Bis(4-hydroxyphenyl)propiononitrile
2,3-Bis(4-hydroxyphenyl)propionitrile >
Benzenepropanenitrile, 4-hydroxy-α-(4-hydroxyphenyl)-
4-Hydroxy-alpha-(4-hydroxyphenyl)benzenepropanenitrile | [Molecular Formula]
C15H13NO2 | [MDL Number]
MFCD01695412 | [MOL File]
1428-67-7.mol | [Molecular Weight]
239.27 |
| Chemical Properties | Back Directory | [Melting point ]
200.0 to 204.0 °C | [Boiling point ]
449.4±35.0 °C(Predicted) | [density ]
1.256±0.06 g/cm3(Predicted) | [RTECS ]
UG0900000 | [storage temp. ]
Desiccate at -20°C | [solubility ]
DMSO: soluble10mg/mL, clear | [form ]
powder | [pka]
9.41±0.26(Predicted) | [color ]
white to beige | [Water Solubility ]
Soluble in 1eq. NaOH (30 mM), ethanol (100 mM), DMSO (100 mM), DMF (~30 mg/ml), and water (0.5 mg/ml at 25°C). | [Stability:]
Stable for 1 year from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20°C for up to 1 month. |
| Hazard Information | Back Directory | [Description]
DPN (1428-67-7) is a potent estrogen ERβ receptor agonist. Displays a 70-fold selectivity over ERα, EC50 = 0.85 and 66 nM, respectively.1 Regulates expression of GluR1, 2 and 3 in rat hippocampus.2 Ameliorates portal hypertension in a carbon tetrachloride-induced liver cirrhosis rat model.3 Stimulates proliferation of androgen-independent prostate cancer cell line PC-3 via a novel pathway involving ERβ-mediated activation of β-catenin.4 A useful tool for elucidating the biological function of ERβ.5 | [Uses]
2,3-Bis(4-hydroxyphenyl)propionitrile is an estrogen receptor β and α specific with pro- and anti-nociceptive actions in mice. | [Definition]
ChEBI: A nitrile that is acetonitrile in which one of the hydrogens is replaced by a 4-hydroxyphenyl group while a second hydrogen is replaced by a 4-hydroxybenzyl group. It is a specific agonist for estrogen receptor beta (ERbeta). | [Biological Activity]
Highly potent estrogen ER β receptor agonist with a 70-fold selectivity over ER α (EC 50 values are 0.85 and 66 nM respectively). Relaxes mesenteric arteries in vitro . | [Biochem/physiol Actions]
2,3-Bis(4-hydroxyphenyl)-propionitrile (Diarylprepionitrile, DPN) is an ERβ-selective agonist; IC50 = 15nM. DPN protects WT and ARKO mice and significantly decreases IL-1β following LPS treatment in young adult-derived microglia. PPT (Cat. No.H6036, ERa agonist) enhances cell proliferation, while DPN inhibits it. PPT increases Bcl-2 expression, while DPN decreases it. DPN also elevates Bax expression. DPN induces a dose-dependent increase on vitellogenin synthesis. PPT and DPN are effective in dynamically, but differentially regulating intracellular calcium signaling in hippocampal neurons. DPN is more efficacious than PPT in potentiating a physiological concentration of glutamate-induced intracellular Ca2+ rise in these neurons. DPN prevents the development of prostatic hyperplasia and inflammation in testosterone-treated LuRKO mice. | [storage]
Desiccate at -20°C | [References]
1) Meyers et al. (2001), Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues; J. Med. Chem., 44 4230
2) Waters et al. (2009), Estrogen receptor alpha and beta specific agonists regulate expression of synaptic proteins in rat hippocampus; Brain Res., 1290 1
3) Zhang et al. (2016), Role of estrogen receptor beta selective agonist in ameliorating portal hypertension in rats with CC14-induced liver cirrhosis; World J. Gastroenterol., 22 4484
4) Lombardi et al. (2016), Estrogen receptor beta (ERβ) mediates expression of β-catenin and proliferation in prostate cancer cell line PC-3; Mol. Cell. Endocrin. 430 12
5) Harrington et al. (2003), Activities of estrogen receptor alpha- and beta-selective ligands at diverse estrogen responsive gene sites mediating transactivation and transrepression; Mol. Cell. Endocrinol., 206 13 |
|
| Company Name: |
|
| Tel: |
821-50328103-801 18930552037 |
| Website: |
https://www.chemicalbook.com/ShowSupplierProductsList13285/0.htm |
|